Domain Associates

Founded in 1985, Domain Associates is a venture capital firm with an exclusive focus on investing in life science companies that advance human health.

[Domain Associates @domainvc]

@IntegenX Applauds the Passage of the Rapid DNA Act of 2017 https://t.co/sVLGYEoQ32

[Domain Associates @domainvc]

ChromaCode Raises $12 Million in Series B for Commercial Launch and Appoints Alex Dickinson as Executive Chair https://t.co/frHKDUys0T

[Domain Associates @domainvc]

Esperion Completes Enrollment of Pivotal Phase 3 Study of Bempedoic Acid in Patients with Hypercholesterolemia https://t.co/wUnL60rXsq

[Domain Associates @domainvc]

MARINUS ANNOUNCES POSITIVE PRELIMINARY DATA FROM CHILDREN WITH CDKL5 GENETIC DISORDER https://t.co/hkQfXRfOYE

[StepStoneVC @StepStoneVC]

.@Allergan to buy @domainvc & @FrazierHealth backed Tobira Therapeutics in $1.7 B deal https://t.co/IfsQxjzoz0

[Domain Associates @domainvc]

Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH https://t.co/8Gapxzxcgh

[Domain Associates @domainvc]

Marinus Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial for Ganaxolone IV https://t.co/Bc7mUfWqbe

[Domain Associates @domainvc]

Jonathan Goodman's vision for Knight Therapeutics is to be a one stop shop for rest of world market #BIO2016

[Domain Associates @domainvc]

.@Bioconlimited CEO - we are a global company that happens to be based in India #BIO2016

[Domain Associates @domainvc]

.@Wharton's Stephen Sammut - most would be surprised to learn that Sub-Saharan Africa is place for innovation in the life sciences #BIO2016

[Domain Associates @domainvc]

Jonathan Goodman - #Canada has 10 different markets, multiple languages and complex regulation that requires expert navigation #BIO2016

[Domain Associates @domainvc]

Partnership with Russian government was key to building NovaMedica #BIO2016

[Domain Associates @domainvc]

Question of the day - What does it take to particiate effectively in complex or non-established markets? #BIO2016

[Domain Associates @domainvc]

Want to learn about biotech in complex markets? Didn't miss the panel happening in north 123 right now #BIO2016

[Domain Associates @domainvc]

More to come at #BIO2016! Join us as @Bioconlimited, Knight Therapeutics & DRI discuss building #biotech in complex markets 10:30a North 123

[Domain Associates @domainvc]

Listen to our discussion on #genomics at #BIO2016 w/ @GenomeAlberta @EdicoGenome @bionanogenomics @IntegratedDx - https://t.co/7QD9bVJN6I

[Domain Associates @domainvc]

Thank you! Honored to be a part of today's events.#BIO2016 https://t.co/tpK5gVeMUF

[Monica May (she/her) @monicamay6]

.@gavinstone: Imagine taking 800 phone books, shredding them, and then reassembling so they make sentences. This is sequencing. #Bio2016

[Monica May (she/her) @monicamay6]

.@gavinstone: We're taking a multidisciplinary approach to a problem that hadn't been optimized previously: big data in genomics #BIO2016

[Monica May (she/her) @monicamay6]

.@gavinstone: Genomics poised to be the biggest of all #bigdata areas, soon to overshadow Twitter #BIO2016